Immunomic Therapeutics, Inc.

Immunomic Therapeutics, Inc. (ITI) is a privately held development-stage biotechnology company. It is principally engaged in developing vaccines and vaccine immunotherapies. The company products are specially designed for treating allergies, HIV and cancers. It uses LAMP ((Lysosome-Associated Membrane Protein) technology to develop its vaccines. Currently, ITI has four vaccines under development. The company operates along with partners, including Geron Corporation, Althea, Nature Pharmaceuticals, NeoVax, Genoa Biotechnologia, S.A. and Ichor Medical Systems. Genoa Biotechnologia, S.A. collaborates with ITI to develop a therapeutic HIV vaccine, namely, Argotom-VAX. ITI is headquartered in Maryland, the US.

Street: 
9290 Gaither Road
City: 
Gaithersburg
Postcode: 
20877
Federal State : 
United States
WebSite: 
www.immunomix.com

Company Index Score

Current Index Score Historical Index Score
  • Immunomic Therapeutics, Inc. currently scores 50 % in the index.
  • Immunomic Therapeutics, Inc. is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • Immunomic Therapeutics, Inc. is currently ranked 1 out of 4535 companies. This is in the top 0.022 % percent of Pharmaceutical companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets